Press-room / Digest

Breakthrough in Preeclampsia Modeling: From 2D Cultures to Placenta-on-a-Chi
Russian scientists have presented an overview of modern cellular models of preeclampsia—a dangerous pregnancy complication. The study covers two-dimensional and three-dimensional cultures, as well as advanced placenta-on-a-chip microfluidic technologies, allowing the examination of pathological mechanisms at the cellular level. The paper highlights the potential of CRISPR-Cas9 and personalized models for developing new diagnostic and therapeutic methods for preeclampsia. These advancements open prospects for more precise early diagnosis of preeclampsia and the creation of effective treatment strategies. Learn more

Photocrosslinking of hyaluronic acid-based hydrogels through biotissue barriers
Application of photocurable hydrogels as biomaterials is one of the goals of tissue engineering. In our work, carried out by scientists from the IBC RAS and other institutes, we propose, instead of traditional UV photoinitiators, photosensitizer derivatives - chlorin p6, chlorin e6 and phthalocyanine - in combination with coinitiators dithiothreitol or 2-mercaptoethanol, which activate photocrosslinking of gels inside the body when irradiated with red light (660-670 nm) falling into the biotissue transparency window. The formation of photo-crosslinked gels based on hyaluronic acid in vitro and in vivo was demonstrated. The gels had a Young's modulus (~270-460 kPa) typical of soft tissues and retained their shape and size in the organism within a month. The work was supported by the RSF, grant 21-79-10384, and published in journal Biomaterials science.

Unveiling the unusual i-motif-derived architecture of a DNA aptamer exhibiting high affinity for influenza A virus
Scientists from IBCH RAS in collaboration with other institutes have established a unique structure of an aptamer to the hemagglutinin of the influenza A virus. The authors showed that the parent aptamer BV42, containing an extended cytosine tract, folded into i-motif, one of the non-canonical nucleic acid structures. However, the conformational heterogeneity of BV42 hindered detailed structural analysis. The use of computational methods and chemical modification helped to identify a potential binding site and apply a unique approach to eliminating conformational diversity while retaining high binding affinity. NMR spectroscopy confirmed the unique structure of the optimized aptamer, containing an i- motif and a duplex module with flexible junction. The results represent significant progress in the rational design of aptamers, highlighting the functional potential of DNA i-motifs for specific protein recognition under physiological conditions. The results are published in Nucleic Acids Research.

The Antigen-Specific Response of NK Cells to SARS-CoV-2 Correlates With KIR2DS4 Expression
The immune response of NK cells to the SARS-CoV-2 virus in the context of the formation of immunological memory remains unknown. Scientists from the IBCh RAS in collaboration with other institutes have established the SARS-CoV-2-specific nature of NK cell responses in COVID-19-experienced individuals. Upon stimulation with SARS-CoV-2 peptides, such donors demonstrated enhanced level of activation, degranulation, IFNγ production, and proliferation of NK cells, as well as upregulation of genes involved in protein transport, metabolism, and immune response. The upregulated gene for activating KIR2DS4 receptor correlated with an enhanced NK cell response to SARS-CoV-2 peptides, indicating a possible role of this receptor in recognizing SARS-CoV-2. The work was supported by RSF grant 22-15-00503 and published in the Journal of Medical Virology.

Upregulation of cholinergic modulators Lypd6 and Lypd6b associated with autism drives anxiety and cognitive decline
A duplication of the chromosomal region 2q23.q23.2, carrying LYPD6 and LYPD6B genes, leads to intellectual disability and autistic features. Researchers from the Neurotransmitter and Neuroreceptor Bioengineering Laboratory, Shemyakin-Ovchnnikov Institute of Bioorganic Chemistry of RAS together with colleagues from Lomonosov State University and Institute for Biomedical Problems of RAS, used a mouse model to study the consequences of overexpression of the Lypd6 and Lypd6b proteins in the brain, which is typical for patients with autism and other neuropsychiatric disorders. A two-week intracerebral infusion of recombinant Lypd6 and Lypd6b analogs impaired memory, increased acute anxiety, reduced dendritic spine density in the hippocampus and amygdala, and led to decreased expression of endogenous Lypd6, Lypd6b, and the α7 nicotinic receptor in the hippocampus. Moreover, in the work I shown that Lypd6b, Like Lypd6, is a negative allosteric modulator of nicotinic receptors. The work is supported by the Russian Science Foundation and published in the journal Cell Death Discovery (IF 6.1).